Livermore

Ponoi Management, LLC

SEC CIK
0001720702

Holdings, Q3 2022

Positions as of Sep 30, 2022, filed Nov 14, 2022.SEC

Positions
4
0 vs. Q2 2022
Total value
$73.24M
+$9.91M (+15.6%) vs. Q2 2022

Compare with Q2 2022: new, added, reduced and sold out

Positions

Long positions only. Changes compare share counts with Q2 2022.

Ponoi Management, LLC holdings in Q3 2022
SecurityClassSharesValue% of portfolioChange in sharesActionHistory
RAPT THERAPEUTICS INC75382E109COM1,599,417$38.48M52.54%00.0%Unchanged–
NGM BIOPHARMACEUTICALS INC62921N105COM1,298,908$16.99M23.20%00.0%Unchanged–
RVMDREVOLUTION MEDICINES INCCOM685,011$13.51M18.44%00.0%UnchangedView
NRIXNURIX THERAPEUTICS INCCOM327,123$4.26M5.82%00.0%UnchangedView

13F filings by quarter

Ponoi Management, LLC 13F filings by quarter
QuarterFiledPositionsTotal valueChangesFiling
Q3 2022Nov 14, 20224$73.24Mvs. Q2 2022SEC
Q2 2022Aug 15, 20224$63.34Mvs. Q1 2022SEC
Q1 2022May 16, 20224$77.04Mvs. Q4 2021SEC
Q4 2021Feb 11, 20224$108.46Mvs. Q3 2021SEC
Q3 2021Nov 12, 20214$112.64Mvs. Q2 2021SEC
Q2 2021Aug 16, 20215$179.97Mvs. Q1 2021SEC
Q1 2021May 17, 20215$170.02M–SEC